All the Drug Class Drugs
Quinolone. Ciprofloxacin (as HCl) 3 mg/ml. EYE AND EAR DROPS (SOL.): 5 ml.
Adults and child from 1 yr:
Corneal ulc.: 2 drops every 15 mins. for
first 6 hrs., then 2 drops every 30 mins.
for rest of day. 2nd day: 2 drops hrly.
On 3rd-14th day: 2 drops every 4 hrs.
for up to 14 days.
Bact. conjunct: 1-2 drops into conjuct.
sac(s) every 2 hrs. for 2 days, then 1-2
drops every 4 hrs. for next 5 days.
Otic use: 3 to 4 drops, 2-4 /d, or more
frequently, if required.
In gen., the duration of tmt does not
exceed 5-10 ds.
For either ind. a max. duration of ther.
of 21 days is recommend.
Corneal ulc., conjunct. caused by suscep.
gram pos., gram neg. microorg. for adults
and ped. pts > 1 yr.
For local./diff. otitis externa accomp. by a
strong inflamm. react. and of which the
strains are suscept., and for the acute flare-up of a chronic otitis media. In this
case, a mucopurulent secret.
In other infect. of the ear in which
Pseudom. aerug. and/or other suscept.
strains may be suspect., it can be used
under the strict superv. of an ear specialist.
It must be understood that this is not a
routine tmt and improper use must be
avoided.
C/I: Hypersens. to the product or other
quinolones.
Fluoroquinolones, Quinolone. Ciprofloxacin (as lactate) 2 mg/ml. BOTTLE: 10, 24 × 100 ml, 200 ml. Dosage ajust. accord. to the type of infec.
Adults: Broad spectrum antibiotic for infec. caused by ciprofloxacin sensit. pathogens.
Child. & adolesc.: Broncho-pulmon., infec. in cystic fibrosis (CF) caused by Pseudomonas a.
Complic. UTS’s and pyelonephritis.
Inhalation anthrax (post-exposure prophylax. & curative tmt.).
Ciprofloxacin may also be used to treat severe infec. in child. & adolesc. when there is no other alternative.
Tmt. should be init. only by physicians who are experienced in the tmt. of CF and/or severe infec. in child. & adolesc.
C/I: Hypersens. to the active ingredient/ other quinolones. Concom. admin. of ciprofloxacin and tizanidine.
Quinolone. Ciprofloxacin (HCl) 250, 500, 750 mg. TABS: 10. Upper and lower respir. tract
infects: 250-750 mg 2 x dly. Upper and
lower urin. tract infects: 250-500 mg 2
x dly. Pneumococ. pneumon. and cystic
fibros. pts. with P. infects. of lower
respir. tract: 750 mg 2 x dly. Other
infects: 500-750 mg 2 x dly. For ped.
cystic fibros. pts. aged 5-17 yrs. with
acute pulm. exacerbat. assoc. with P.
aeruginosa infects: 20 mg/kg 2 x dly.
Max. dly dose: 1,500 mg.
Infects. caused by ciprofloxacin-sens.
pathogens: tmt. invas. infect. extern. ear;
tmt. acute pulm. exacerbat. of cystic
fibrosis assoc. with Pseudomonas
aeruginosa in ped. pts. aged 5-17 yrs.
C/I: Known hypersens. to ciprofloxacin or
other quinolone deriv., child. and grow.
adolesc., pregn., lact.
Quinolone. Levofloxacin (as Hemihydrate) 500 mg. TABS: 5. 1 tab 1-2 x dly for up to 14
days.
Mild to mod. infects. incl. acute sinusit.,
acute chron. bronchit., common acq.
pneumon., complicat. urin. tract infects.,
skin and soft tissue infects.
C/I: Hypersens., epilepsy, fluroquinolone
related tendon disords., pregn., lact.,
child up to 18 yrs.
Quinolone. Moxifloxacin 400 mg / 250 ml. INFUS. SOLN: 250 ml. 400 mg (oral. tab. or as an IV infus.) once every 24 hrs. The duration of ther. depend. on the type of infec.
Acute Bact. Sinus. Acute: 10d
Bact. Exacerbat. of Chron. Bronchit.: 5d
Commun. –Acquir. Pneumon.: 7-14d
Uncomplic. Skin & Skin Structure Infec. (SSSI): 7d
Complic. SSSI: 7-21 d. See lit.
Tmt. of adult. (>18 yrs. of age) with Commun. Acquir. Pneumon. caused by streptococc. pneumon., haemophil. influenz. moraxella catarrhalis, staphylococ. aureus, klebsiella pneumon. mycoplasma pneumon. or chlamydia pneumon. and Complica. skin & skin Struct. Infect. caused by methicillin susceptib. staphylococcus aureus, escherichia coli, klebsiella pneumon. or enterobacter cloacae.
Appropriate culture and susceptibil. tests should be perform. before tmt. in order to isolate and identify organis. causing infec. and to determine their susceptibil. to moxifloxacin.
Ther. may be initiated before results of these tests are known; once results become available, appropr. ther. should be cont.
C/I: Hypersens. to compon. or other quinolones.
Quinolone. Moxifloxacin (as HCl) 400 mg. F.C. TABS: 5. 400 mg (oral. tab. or as an IV infus.) once every 24 hrs. The duration of ther. depend. on the type of infec.
Acute Bact. Sinus. Acute: 10d
Bact. Exacerbat. of Chron. Bronchit.: 5d
Commun. –Acquir. Pneumon.: 7-14d
Uncomplic. Skin & Skin Structure Infec. (SSSI): 7d
Complic. SSSI: 7-21 d. See lit.
For the tmt. of the follow. bact. infect. in pts. of 18 years & older:
Respir. infec.: - Uncomplic. Acute bact. sinusit, (ABS)
- Acute exacerb. of chron. bronchit. (AECB)
The tabs. should be used to treat adeq. diagn, ABS and AECB only when it is considered inappropr. to use antibact. agents that are commonly recomm. for the init. tmt. of these infec. or when these have failed to resolve the infec.
-Commun. acquir. pneum., except severe cases.
The tabs. should be used only when it is consid. inappropr. use antibact. agents that are common. recomm. for the init. tmt. of this infec.
C/I: Hypersens. to compon. or other quinolones.
